COVID treatments in short supply in some parts of the country

Pfizer and Merck COVID treatment pills are in short supply in some parts of the nation. The scramble for treatments comes as the FDA pulled emergency authorization for monoclonal antibody treatments by Regeneron and Eli Lilly.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting